Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Nissen‑Sleeve versus Roux‑en‑Y gastric bypass for reflux in people with severe obesity

Official title: The SLEEVE-GERD Trial: A Comparative Study of Nissen-Sleeve and Roux-en-Y Gastric Bypass in Obese Patients With GERD

Run by Jagiellonian University · NCT07158008 · Data updated 2026-11-12

This trial tests whether Nissen‑Sleeve gastrectomy or Roux‑en‑Y gastric bypass better controls GERD symptoms in adults who are eligible for bariatric surgery due to severe obesity.

More Bariatric Surgery trials

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment560 (estimated)
SponsorJagiellonian University
Academic / other
Locations1 site (Krakow)
StatusRecruiting
StartedJuly 31, 2025
Main results expectedJuly 31, 2028
Study endsSeptember 2028
Registry record updatedSeptember 5, 2025
Trial IDNCT07158008 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18 years) eligible for bariatric surgery (BMI ≥40 or ≥35 with comorbidities) who have symptomatic GERD defined by regular PPI use, a GerdQ >6, or endoscopic esophagitis, and who have not had prior upper GI or anti‑reflux surgery and are non‑smokers.

Probably not a fit

Patients without GERD, those with prior upper gastrointestinal or anti‑reflux surgery, active smokers, or those not eligible for bariatric surgery are unlikely to benefit from enrollment in the randomized comparison.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized trial will directly compare Nissen‑Sleeve gastrectomy (a sleeve gastrectomy combined with a 360° fundoplication wrap) to Roux‑en‑Y gastric bypass (RYGB) in adults with obesity and symptomatic GERD, with an observational sleeve gastrectomy group for patients without GERD. Participants meeting bariatric criteria and GERD definitions will be randomized to N‑SG or RYGB and followed for safety, reflux control, nutritional outcomes, and need for further procedures. The trial highlights differences in anatomical alteration, endoscopic access to the biliary tree, and potential long‑term nutritional risks between the two approaches. Outcomes will inform whether the newer N‑SG technique can match RYGB’s reflux control while preserving gastrointestinal continuity.

Why it matters

Potential benefit: If successful, the Nissen‑Sleeve approach could offer similar reflux control to RYGB while preserving normal GI continuity and reducing long‑term nutritional issues and limitations on endoscopic access.

How similar studies have gone: Roux‑en‑Y gastric bypass is an established, effective anti‑reflux bariatric operation, while Nissen‑Sleeve is a newer hybrid technique with encouraging early observational reports but limited randomized data to date.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

For N-Sleeve Gastrectomy (N-SG) and Roux-en-Y Gastric Bypass (RYGB) arms:

* Age ≥ 18 years
* Written informed consent provided
* Eligible for bariatric surgery according to national guidelines (BMI ≥ 40 kg/m² or BMI ≥ 35 kg/m² with obesity-related comorbidities)
* Presence of symptomatic gastroesophageal reflux disease (GERD), defined by at least one of the following:
* Regular use of proton pump inhibitors (PPIs)
* GerdQ score \> 6
* Endoscopic evidence of esophagitis (Los Angeles classification grade B or higher)

For Sleeve Gastrectomy (SG) observational control group:

* Age ≥ 18 years
* Written informed consent provided
* Eligible for bariatric surgery according to national guidelines (BMI ≥ 40 kg/m² or BMI ≥ 35 kg/m² with obesity-related comorbidities)
* No symptoms or history of GERD

Exclusion Criteria:

* History of prior anti-reflux surgery
* History of upper gastrointestinal tract surgery
* Active smoking or history of nicotine use
* Severe cardiac insufficiency (New York Heart Association Class III or IV)
* Pregnancy or planned pregnancy during the study period (if applicable based on future additions)
* Any condition that, in the opinion of the investigator, would interfere with the participant's ability to comply with the study protocol or would pose additional risk

Where it's running

  • Szpital Uniwersytecki w Krakowie
    Krakow, Poland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.